Sign In
Buy SBFM
$2.05
-0.0800 (-3.76%)
At Close: Jun 22, 2026
Sunshine Biopharma Announces Canadian Approval for Rivaroxaban, a Generic Form of Xarelto(R)
08:00am, Monday, 01'st Jun 2026
FORT LAUDERDALE, FL / ACCESS Newswire / June 1, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription medica
Sunshine Biopharma Announces Issuance of U.S. Patent 12,624,066 B2 Covering Novel Coronavirus Treatment Technology
08:00am, Friday, 29'th May 2026
FORT LAUDERDALE, FL / ACCESS Newswire / May 29, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription medica
Why Sunshine Biopharma (SBFM) Stock Dropped After Hours Today
02:16am, Friday, 29'th May 2026
Sunshine Biopharma stock fell after hours after the company announced a 1-for-10 reverse stock split to maintain Nasdaq listing compliance.
Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing
09:00am, Thursday, 28'th May 2026
FORT LAUDERDALE, FL / ACCESS Newswire / May 28, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription medica
Sunshine Biopharma Stock Rallies On Canadian Approval For Generic Amoxicillin
09:31am, Thursday, 21'st May 2026
Sunshine Biopharma (NASDAQ: SBFM) shares are trading higher Thursday after securing Canadian regulatory approval for generic amoxicillin.
Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Amoxicillin
07:00am, Thursday, 21'st May 2026
FORT LAUDERDALE, FL / ACCESS Newswire / May 21, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription medica
Sunshine Biopharma Inc. Announces Closing of up to $18.0 Million Public Offering
12:05pm, Tuesday, 19'th May 2026
$6.0 million upfront with up to an additional approximately $12.0 million of potential aggregate gross proceeds upon the exercise in full of warrants. FORT LAUDERDALE, FL / ACCESS Newswire / May 19, 2
Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering
12:15pm, Monday, 18'th May 2026
FORT LAUDERDALE, FL / ACCESS Newswire / May 18, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and developing life‑saving medicines across oncology,
Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year
08:30am, Monday, 06'th Apr 2026
FORT LAUDERDALE, FL / ACCESS Newswire / April 6, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) ("Sunshine Biopharma" or the "Company"), a pharmaceutical company offering and developing life‑saving me
Sunshine Biopharma (NASDAQ:SBFM) Trading Up 4.1% – Should You Buy?
03:33am, Thursday, 22'nd Jan 2026
Sunshine Biopharma, Inc. (NASDAQ: SBFM - Get Free Report) shares were up 4.1% during mid-day trading on Wednesday. The stock traded as high as $1.28 and last traded at $1.26. Approximately 49,259 shar
Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM)
02:10pm, Tuesday, 28'th Oct 2025
FORT LAUDERDALE, FL / ACCESS Newswire / October 28, 2025 / Momentum has a way of separating the contenders from the crowd. Sunshine Biopharma (NASDAQ: SBFM ) is quickly establishing which side of that
Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea
07:45am, Tuesday, 28'th Oct 2025
FORT LAUDERDALE, FL / ACCESS Newswire / October 28, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company focused on innovative and affordable healthcare solut
Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline
07:45am, Monday, 20'th Oct 2025
FORT LAUDERDALE, FL / ACCESS Newswire / October 20, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company focused on innovative and affordable healthcare solut
Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin
07:45am, Thursday, 16'th Oct 2025
FORT LAUDERDALE, FL / ACCESS Newswire / October 16, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety o
Sunshine Biopharma is Proving That Riding Momentum is an Effective Strategy (NASDAQ:SBFM)
10:45am, Tuesday, 14'th Oct 2025
FORT LAUDERDALE, FL / ACCESS Newswire / October 14, 2025 / Sunshine Biopharma (NASDAQ: SBFM ) is quietly engineering a flywheel model for biotech. Not a flashy one that spins fast and burns energy and
